Andrew has over 25+ years of professional experience at growth oriented private equity backed companies and leading global investment banks. In his most recent experience, Andrew was the SVP for Finance at Certara, Inc. [CERT], a $3.5bn Nasdaq listed leader in biosimulation. At Certara, Andrew established and scaled the FP&A function, and was a member of the core deal team who architected and led the sale of the company in 2017 by Arsenal Capital to EQT Partners for $850m and the initial public offering (“IPO”) of the company in 2020 that raised $769m. Before Certara, Andrew worked for Apollo and Tiger Global backed companies implementing buy and build strategies. Andrew also worked for global investment banks, notably Deutsche Bank and Bank of America, where he specialized in M&A advisory and executed over 40 domestic and cross-border M&A transactions with an aggregate value of over $9 billion. Andrew holds an MBA from Columbia Business School (Beta Gamma Sigma) and a BA in Economics from Vanderbilt University (cum laude).